[Antifungal resistant fungi].
Maesaki
Shigefumi
S
Department of Infectious Disease & Infection Control, Saitama Medical School.
D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D001230:Aspergillus / Q000187:drug effects*; D002175:Candida / Q000187:drug effects*; D003454:Cryptococcus / Q000187:drug effects*; D025141:Drug Resistance, Fungal / Q000235:genetics; D004359:Drug Therapy, Combination; D005656:Fungal Proteins; D006801:Humans; D026901:Membrane Transport Proteins; D009181:Mycoses / Q000188:drug therapy / Q000382:microbiology
D000935:Antifungal Agents; C094693:CDR1 protein, Candida albicans; D005656:Fungal Proteins; D026901:Membrane Transport Proteins